ZOM - הכנסה תפעולית לפני ניכוי פחת Zomedica Corp.

Zomedica Corp. generates revenue through the sale of TRUFORMA rapid diagnostic systems for veterinary practitioners. The integration of Pulsevet laser devices and specialized cartridges creates a closed service ecosystem for clinics. The company is also optimizing logistics to reduce plastic waste. Absolute profit from core operations demonstrates financial stability, where determines this parameter level.

For Zomedica Corp. (ZOM), the EBITDA chart serves as an indicator of the effectiveness of its veterinary equipment sales strategy during a period of structural business adaptation. This metric isolates operating cash flow from the impact of depreciation and taxes, allowing investors to assess the company's actual margin of safety and management's proximity to reaching the break-even point.